subject: Aarkstore Enterprise - Medtronic To Acquire Ats Medical - Market Research [print this page] Medtronic to Acquire ATS Medical Medtronic to Acquire ATS Medical
Summary
Medtronic, Inc., a medical device company, signed a definitive agreement to acquire ATS Medical, Inc., a cardiovascular devices company, for a purchase consideration of approximately $370 million or $4 per share in cash. The transaction includes the purchase of ATS Medical stock and assumption of net debt.
The proposed acquisition of ATS Medical is specifically aimed at strengthening and completing Medtronics portfolio of therapies for the treatment of cardiac arrythmias and heart valve diseases. Through the acquisition of CryoCath Technologies in 2008 and Ablation Frontiers in 2009, Medtronic acquired a strong portfolio of products that treat cardiac arrythmias in a minimally invasive nature. Simialry, with the acquisition of Corevalve and Ventor Technologies in 2009 the company had acquired a huge portfolio of minimally invasive heart valve replacement technologies. According to GlobalData ATS Medical is a well thought out acquisition made by Medtronic that will add value to Medtronics previous acquisitions and its current product portfolio.
Scope
- Details of the agreement included
- Rationale behind the deal
- Strategic fit assessment of ATS and Medtronics products
- Company Profiles for ATS Medical and Medtronic
Reasons to buy
- Identify key M&A trends in the medical equipment market
- Track competitor product portfolios and acquisition trends
- Assess future outlook of the companies in question
